Announcing The Cure Trap: Why the Most Funded Word in Medicine Keeps Failing Patients

For the last ten years, I have lived in the space between the clinic and the laboratory. Today, I am releasing the culmination of that decade: my new book, The Cure Trap: Why the Most Funded Word in Medicine Keeps Failing Patients. At its core, the book confronts a central, devastating contradiction: we have built a biomedical system that demands answers in two to five years for complex diseases that take decades to unfold. Worse, our obsession with marketing a singular ‘cure’ is the very thing keeping us trapped.

You won’t find this book behind a retail paywall or on a publisher’s release schedule, and that is by design. Having co-authored two traditionally published books, I know firsthand how that machine works: you hand over a manuscript, wait nine to twelve months for committees to sand down its sharper edges, and finally release a $20 paperback long after the urgent debates inside it have gone stale. Doing that with a book that critiques slow, self-preserving institutional timelines would have been a contradiction in terms.

That doesn’t mean this manuscript wasn’t rigorously stress-tested: over the past months, it went through more than thirty revisions and fifty independent reviews by movement disorder specialists, biomedical researchers, biotech leaders, colleagues, and friends who challenged every argument within. What it didn’t go through is a corporate filter. The specific trials, capital allocations, and foundation strategies examined in these pages are happening right now. As much as my vanity wants to see this as a printed book I can hold in my hands, releasing The Cure Trap directly on Tomorrow Edition as an immediate, free download is the right thing to do. It ensures two things traditional publishing never could: zero censorship of the text, and zero delay in getting it into the hands of the patients, researchers, trial designers, and funders who need to grapple with it today.

What you are getting is the unfiltered distillation of ten years on the front lines of neurodegenerative research and advocacy. Soon after I was diagnosed with Parkinson’s at 29 while living in Shanghai, I wrote:

“So, where to go? Who to talk to? At any other time in history the best I would have been able to do is travel for miles to the nearest specialist (or witch doctor) and rely solely on whatever ill-informed advice he or she would have had for me. But, we live in remarkable times and I soon realized I had more resources at my disposal than any king or emperor had ever dreamed.”

Over the past decade, I pushed the resources now available to their limit. The digital and scientific infrastructure of our era allowed me to walk into dozens of academic laboratories around the globe, interrogate hundreds of researchers and biotech executives, co-author books with world-leading neurologists, chair patient advisory boards, and help direct millions of dollars in fellowship and research funding. I have watched clinical trials get designed from the inside, and I have had holes drilled into my own skull during awake deep brain stimulation surgery while debating the very circuit dynamics being modulated. No generation of patients before ours has ever had the keys to the back rooms of biomedical science. Because I was given that access, I have an obligation to report back on what actually happens when the doors close.

What You Will Find Inside

The Cure Trap is part investigative memoir, part institutional autopsy, and part blueprint for reform. When you download the full text, here is what you will have access to:

• An Anatomy of the “Cure Economy”: Why the promise of a singular, monolithic “cure” has become the most lucrative fundraising mechanism in modern medicine, and how that exact marketing imperative systematically distorts science, starves symptomatic and circuit-level breakthroughs, and rewards the appearance of momentum over biological reality.
• Why One-Size-Fits-All Trials Keep Failing: How our current clinical trial architecture clings to broad, outdated 19th-century clinical labels and narrow genetic targets, treating the massive biological heterogeneity of patients as statistical noise rather than the central problem to be solved.
• Behind-the-Scenes Disclosure: A transparent look at how funding priorities are actually set, how patient advisory boards are routinely used as cosmetic rubber stamps, as well as the quiet doubts that principal investigators and biotech leaders admit over dinner but never put into a grant application or press release.
• A Concrete Blueprint for Reform: How we dismantle the current bottleneck by shifting toward disease-agnostic basket trials rooted in shared biology, integrating continuous real-world digital telemetry over episodic clinic snapshots, and moving to a “pay, train, and embed” model that puts compensated patient experts directly into research governance.

Why I Named Names

In the medical advocacy world, there is an unspoken pact of civility. Patients are expected to be grateful, inspiring, and endlessly patient; institutions and researchers are critiqued only in vague, diplomatic abstractions so that nobody’s funding stream or reputation is threatened.

I broke that pact in this book. In these pages, I name names: specific institutions, specific foundations, specific trials, and specific decision-makers.

I didn’t do this to settle personal scores or engage in tabloid takedowns. Nearly everyone I critique in this book entered this field with good intentions. The problem is that when critiques remain abstract, everyone in the room nods along and assumes you are talking about someone else. Abstraction protects the status quo. By naming names and pointing to exact decisions, programs, and capital allocations, my goal is to force a level of institutional accountability that polite conference panels never achieve. If we can’t speak honestly about which specific bets failed, which incentives warped the science, and who signed off on them, we condemn the next decade of both patients and researchers to repeat the exact same cycle.

My Opus

As egotistical as it sounds to say out loud: this book is my opus. It is what it is.

To be clear, this isn’t a swansong. I am not stepping back from my work in the field, from my roles advising companies and foundations, or from the fight to overhaul how trials are run. But as a piece of writing, this is the summit. I have poured a decade of global travel, hundreds of hours of interviews, hard-won institutional access, and my own physical and neurological reality into this manuscript. Everything I have learned about why biomedical research is stuck, and how we actually fix it, is right here on the page.

Download the book, argue with it, send it to your neurologist, or drop it on the desk of your foundation’s board. Just don’t ignore it.

[Download the Full PDF of The Cure Trap Here]

[Download the EPUB (Kindle / Apple Books) Here]

Prefer a Physical Copy, Audiobook, or Kindle Version? Here are Your Options:

Because I wanted to release this immediately without waiting on traditional print schedules or locking it behind Amazon’s ecosystem, I am giving you the complete digital files directly today. Over the coming weeks, I may also highlight specific chapters here on Tomorrow Edition. If there is enough demand from readers who prefer paper and ink, I will set up a print-on-demand paperback option down the road.

However, nobody enjoys reading a book-length PDF on a computer monitor, and for many in the Parkinson’s community, holding a screen or tracking small text is a physical chore. So, if you prefer to listen to this as an audiobook or read it on an e-reader right now, modern tools make it effortless to convert this file yourself for free:

• To Listen as an Instant AI Audiobook (iOS & Android): Download the ElevenReader app (by ElevenLabs—free on iOS and Android), upload the PDF or EPUB directly into the app, and it will narrate the entire book using realistic, human-like AI voices. (Personally, I get a strange satisfaction out of listening to Michael Caine saying my words.) If you are on Android and prefer granular offline control over playback speed and text navigation without creating an account, load the PDF into @Voice Aloud Reader.
• To Read on a Kindle: Go to amazon.com/sendtokindle on your browser, drag and drop the downloaded file (use the EPUB version if possible for clean font resizing), and it will appear in your Kindle library across all your devices within two minutes. Alternatively, email the file to your personal Send-to-Kindle address (if emailing the PDF, type CONVERT in the subject line so Amazon automatically reformats the text to fit your screen).
• To Read on Apple Books or Kobo: On an iPhone, iPad, or Mac, simply tap the downloaded file and select Share -> Books to load it into Apple Books with full bookmarking and dark-mode support. For Kobo, drag and drop the file via USB or upload it to your linked Google Drive or Dropbox folder.